제주대학교 Repository

NMDA 수용체 길항제를 통한 성상교세포 칼슘 흥분성 조절기전에 대한 연구

Metadata Downloads
Alternative Title
Study on the modulatory function of calcium excitability in astrocytes by NMDA receptor antagonists
Abstract
Astrocytes, the predominant cell type in central nervous system, are electrically non-excitable cells. However, astrocytes display their excitability by increasing intracellular calcium concentration. Several lines of evidence have highlighted the importance of astrocytic calcium excitability in both physiological and pathological conditions. Here, we investigated the effects of dissociated anesthetics: ketamine and MK-801 (dizocilpine), NMDA (N-methyl-D-aspartate) receptor antagonists, on calcium excitability in mouse cortical astrocytes. We further compared the effects of Ketamine and MK-801 on astrocytic serotonin (5-HT) receptors. In cultured cortical astrocytes, MK-801 increased intracellular calcium concentration and led to further increases in calcium in the presence of 5-HT. However ketamine had no effect on the calcium response in astrocytes. These results suggest that the calcium concentration in astrocytes is reinforced by MK-801 under the modulation of serotonin receptors.
Author(s)
Oyunbileg Dash
Issued Date
2016
Awarded Date
2016. 8
Type
Dissertation
URI
http://dcoll.jejunu.ac.kr/jsp/common/DcLoOrgPer.jsp?sItemId=000000007670
Alternative Author(s)
대어윤 블렉
Department
대학원 의생명신약개발학과
Advisor
정성철
Table Of Contents
ABSTRACT Ⅰ
목 차 Ⅱ
Ⅰ. 서론 1
Ⅱ. 연구방법 4
1. 세포배양 4
2. 칼슘 이온농도 측정 (calcium imaging) 4
3. 자료분석 5
Ⅲ. 결과 6
1. NMDA 수용체 길항제인 디조실핀 (MK-801)의 의한 칼슘이온농도 변화 6
2. 디조실핀 (MK-801)에 의해서 유도된 칼슘 반응에 대한 NMDA 수용체 길항제 D-AP5의 억제 9
3. 5-HT 존재 하에 NMDA 수용체 길항제인 디조실핀 (MK-801)의 의한 칼슘이온농도 변화 12
4. NMDA 수용체 길항제인 Ketamine에 의한 칼슘이온농도 변화 15
Ⅳ. 고찰 18
Ⅴ. 참고문헌 23
Degree
Master
Publisher
제주대학교 대학원
Citation
Oyunbileg Dash. (2016). NMDA 수용체 길항제를 통한 성상교세포 칼슘 흥분성 조절기전에 대한 연구
Appears in Collections:
General Graduate School > Biomedicine and Drug Development
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.